(1R,4R)-METHYL 4-CARBAMOYLCYCLOHEXANECARBOXYLATE, 97.0%, 1g

4-Methylquinoline-2-carbonitrile, 97%, 5g

1-Bromo-3-[(2-methylpropoxy)methyl]benzene, 95%, 2.5g

Ethynylcyclohexane, 95.0%, 25g

1-Chlorooctadecane, 95.0%, 1kg

N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethanesulfonamide, 98%, 1g

Colonna capillare per GC ROTI®Cap-5 MS, 50 m, 0.20 mm, 0.35 µm, 1 Pezzo(i)

5,5',6,6'-Tetrahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindane>96.0%(HPLC)(T)25g

Methyl (2S,4R)-4-amino-1-Boc-pyrrolidine-2-carboxylate, 95.0%, 5g

Ethyl 1-(azetidin-3-yl)-1H-1,2,3-triazole-4-carboxylate hydrochloride, 5g

3-(1-Ethoxyethoxy)oxetane, 95.0%, 1g

Methyl 2-(2,5-dimethylthiazol-4-yl)acetate, 95.0%, 1g

6-(4-Bromo-phenyl)-3H-thieno[3,2-d]pyrimidin-4-one, 100mg